Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,725,971
-
Share change
-
-1,474,706
-
Total reported value
-
$18,154,786
-
Price per share
-
$2.69
-
Number of holders
-
28
-
Value change
-
-$5,363,149
-
Number of buys
-
13
-
Number of sells
-
16
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q2 2015
As of 30 Jun 2015,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,725,971 shares.
The largest 10 holders included
Versant Venture Management, LLC, ADAGE CAPITAL PARTNERS GP LLC, JENNISON ASSOCIATES LLC, Lombard Odier Asset Management (USA) Corp, Point72 Asset Management, L.P., Visium Asset Management, LP, EverPoint Asset Management, LLC, VANGUARD GROUP INC, Iguana Healthcare Management, LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.